21 CFR Part 820 · Quality System Regulation (before Feb 2, 2026)

21 CFR 820.50

Purchasing controls

21 CFR 820.50 is the regulation titled “Purchasing controls” in 21 CFR Part 820, Quality System Regulation (before Feb 2, 2026). Since 2021, 49 FDA warning letters have cited it.

Part 820 changed when FDA's Quality Management System Regulation took effect on February 2, 2026. This is the earlier text these letters cite.

Letters citing it
49 since 2021
Jan 1 to Oct 30, 2026
7 against 15 on the same dates in 2025
Most often cited with
21 CFR 820.30, in 40 letters
Closed out
14% of these letters have a published close-out
See the 49 letters citing 21 CFR 820.50 →

Letters citing it, by year issued

Most are medical device letters (48 of 49). 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 22021
  2. 62022
  3. 82023
  4. 92024
  5. 172025
  6. 72026

What FDA writes when it cites it

The finding headings that cite 21 CFR 820.50 most often, as written in the letters.

  • 4 lettersFailure to establish and maintain procedures to ensure that all purchased or otherwise received product and services conform to specified requirements, as required by 21 CFR 820.50
  • 2 lettersFailure to adequately establish and maintain procedures to ensure that all purchased or otherwise received product and services conform to specified requirements, as required by 21 CFR 820.50
  • 2 lettersFailure to adequately establish procedures to ensure that all purchased or otherwise received product and services conform to specified requirements, as required by 21 CFR 820.50

The regulation

Read the text of 21 CFR 820.50 (eCFR, as of Jun 1, 2025)

Each manufacturer shall establish and maintain procedures to ensure that all purchased or otherwise received product and services conform to specified requirements.

(a) Evaluation of suppliers, contractors, and consultants. Each manufacturer shall establish and maintain the requirements, including quality requirements, that must be met by suppliers, contractors, and consultants. Each manufacturer shall:

(1) Evaluate and select potential suppliers, contractors, and consultants on the basis of their ability to meet specified requirements, including quality requirements. The evaluation shall be documented.

(2) Define the type and extent of control to be exercised over the product, services, suppliers, contractors, and consultants, based on the evaluation results.

(3) Establish and maintain records of acceptable suppliers, contractors, and consultants.

(b) Purchasing data. Each manufacturer shall establish and maintain data that clearly describe or reference the specified requirements, including quality requirements, for purchased or otherwise received product and services. Purchasing documents shall include, where possible, an agreement that the suppliers, contractors, and consultants agree to notify the manufacturer of changes in the product or service so that manufacturers may determine whether the changes may affect the quality of a finished device. Purchasing data shall be approved in accordance with § 820.40.

Text from eCFR as of Jun 1, 2025.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 820.50.

Latest letters citing it

The 3 letters citing 21 CFR 820.50 that FDA posted most recently.

See the 49 letters citing 21 CFR 820.50 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.